Proteomics Tools 2.0: Evaluating Next-Generation Solutions

Overview

Herein we detail how next generation proteomics tools are solving limitations of traditional tools (IHC, ELISA, Mass Spectrometry, Flow Cytometry) and are adding functionality.

After years of relatively stagnant innovation in traditional proteomics tools, there are a myriad of new solutions that could lead to material advancements in the field. We estimate that the market opportunity across all classes of proteomics tools (traditional and emerging) could approximate if not exceed $50B.

 

Contact

Headshot DB

Dierk
Beyer

Partner
M&A

+49 69 5060 675 62
Email

Order report

    Request the full report.

    Similar Insights

    Pharma Services MA Update February 2023
    Image Pharma Services Report May 22
    Insights Cowen Valued-Based Care Health Care Business Model Transformation